Mechanistic Insights Into Ganoderma Lucidum for Diabetes Treatment via Network Pharmacology and Validation.

Ganoderma lucidum

OncologyImmune supportMetabolic healthLiver support

SpeciesReishi, Lingzhi

JournalDiabetes, metabolic syndrome and obesity: targets and therapy

Year2025

Metadata-grounded summary

Article summary

Metadata-grounded summary: This research article indexes research on Ganoderma lucidum in Diabetes, metabolic syndrome and obesity: targets and therapy in 2025. MycoData maps the paper to oncology, immune support, metabolic health, liver support based on its title, species context, article metadata, and study classification.

Citation

Guo S, Yang L, Zhou J, Luo W, Nie B, Zhong X, et al. (2025). Mechanistic Insights Into Ganoderma Lucidum for Diabetes Treatment via Network Pharmacology and Validation. Diabetes, metabolic syndrome and obesity: targets and therapy https://doi.org/10.2147/DMSO.S500955 PMID: 40291539

Open citation